NCT04975542

Brief Summary

This study focused on improving breathing mechanics by using various osteopathic manipulative therapy (OMT) techniques. The investigators randomly assigned participants to a control group who received sham treatment and a treatment group who received OMT. The investigators measured variable pre- and post- treatment on both groups. The investigators observed an improvement in breathing mechanics in the treatment group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 23, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
Last Updated

July 23, 2021

Status Verified

July 1, 2021

Enrollment Period

5 months

First QC Date

May 19, 2021

Last Update Submit

July 14, 2021

Conditions

Keywords

Breathing MechanicsOsteopathic Manipulative TreatmentChest Wall ExcursionPulmonary Function Tests

Outcome Measures

Primary Outcomes (4)

  • Change in chest wall excursion

    M1 and M2 measurements with a soft tape measure. M1: Level of sternal notch (in centimeters), M2: Level of xiphoid process (in centimeters).

    Measure assessing a change from baseline chest wall excursion within 5 minutes of treatment completion.

  • Change in forced vital capacity (FVC)

    Measurement of Forced Vital Capacity (FVC) as measured via pulmonary function testing.

    Measure assessing a change from baseline FVC value via pulmonary function testing within 5 minutes of treatment completion.

  • Change in forced expiratory volume at 1 second (FEV1)

    Measurement of Forced Expiratory Volume at 1 second (FEV1) as measured via pulmonary function testing.

    Measure assessing a change from baseline in forced expiratory volume at 1 second via pulmonary function testing within 5 minutes of treatment completion.

  • Change in FEV1/FVC ratio

    Measurement of a ratio between FEV1 and FVC values that are obtained through pulmonary function testing.

    Measure assessing a change from baseline FEV1/FVC ratio value via pulmonary function testing within 5 minutes of treatment completion.

Secondary Outcomes (3)

  • Change in respiratory rate

    Measure assessing a change from baseline respiratory rate within 5 minutes of treatment completion.

  • Change in heart rate

    Measure assessing a change from baseline heart rate within 5 minutes of treatment completion.

  • Oxygen Saturation (spO2)

    Measure assessing a change from baseline oxygen saturation within 5 minutes of treatment completion.

Study Arms (2)

Treatment Group

EXPERIMENTAL
Other: Osteopathic Manipulative Medicine

Sham Group

SHAM COMPARATOR
Other: Sham

Interventions

Manipulative therapies based on Osteopathic principles.

Treatment Group
ShamOTHER

Light touch techniques to mimic to osteopathic treatment.

Sham Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers from Touro College of Osteopathic Medicine (TouroCOM), including students and staff, were recruited as subjects of this study. Any participant with recent or past medical history of obstructive or restrictive lung disorders, recent trauma, or illnesses, and/or chest abnormalities were excluded from the study.

You may not qualify if:

  • Certain study results were excluded on the basis of abnormal baseline measurements, including but not limited to, heart rate, oxygen saturation, respiratory rate, improper spirometer use, technique and/or high variance among the repeated measurements obtained for each participant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Touro College of Osteopathic Medicine

New York, New York, 10027, United States

Location

Related Publications (5)

  • Noll DR, Degenhardt BF, Stuart M, McGovern R, Matteson M. Effectiveness of a sham protocol and adverse effects in a clinical trial of osteopathic manipulative treatment in nursing home patients. J Am Osteopath Assoc. 2004 Mar;104(3):107-13. No abstract available.

    PMID: 15083985BACKGROUND
  • Zanotti E, Berardinelli P, Bizzarri C, Civardi A, Manstretta A, Rossetti S, Fracchia C. Osteopathic manipulative treatment effectiveness in severe chronic obstructive pulmonary disease: a pilot study. Complement Ther Med. 2012 Feb-Apr;20(1-2):16-22. doi: 10.1016/j.ctim.2011.10.008. Epub 2011 Nov 27.

    PMID: 22305244BACKGROUND
  • Guiney PA, Chou R, Vianna A, Lovenheim J. Effects of osteopathic manipulative treatment on pediatric patients with asthma: a randomized controlled trial. J Am Osteopath Assoc. 2005 Jan;105(1):7-12.

    PMID: 15710659BACKGROUND
  • Kaneko H, Shiranita S, Horie J, Hayashi S. Reduced Chest and Abdominal Wall Mobility and Their Relationship to Lung Function, Respiratory Muscle Strength, and Exercise Tolerance in Subjects With COPD. Respir Care. 2016 Nov;61(11):1472-1480. doi: 10.4187/respcare.04742. Epub 2016 Oct 18.

    PMID: 27794081BACKGROUND
  • Lorenzo S, Nicotra CM, Mentreddy AR, Padia HJ, Stewart DO, Hussein MO, Quinn TA. Assessment of Pulmonary Function After Osteopathic Manipulative Treatment vs Standard Pulmonary Rehabilitation in a Healthy Population. J Am Osteopath Assoc. 2019 Feb 11. doi: 10.7556/jaoa.2019.026. Online ahead of print.

    PMID: 30741314BACKGROUND

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

salicylhydroxamic acid

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Mikhail Volokitin, MD, DO

    Touro College of Osteopathic Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Student

Study Record Dates

First Submitted

May 19, 2021

First Posted

July 23, 2021

Study Start

September 23, 2019

Primary Completion

March 5, 2020

Study Completion

March 5, 2020

Last Updated

July 23, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations